The Claim
Hepatic deletion of DDB1 in mice fed a high-fructose diet reduces ChREBPα protein stability, decreases expression of FASN, ACC1, and SCD1, and lowers liver triglyceride accumulation by approximately 50%, demonstrating that DDB1 is necessary for fructose-induced de novo lipogenesis and steatosis in this model.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice consuming a high-fructose diet, removing the DDB1 gene from liver cells reduces the stability of the ChREBPα protein, lowers the levels of key fat-producing enzymes, and decreases liver fat accumulation by about 50%.
See the scientific wording
In mice fed a high-fructose diet, hepatic deletion of DDB1 reduces ChREBPα protein stability, decreases expression of lipogenic enzymes (FASN, ACC1, SCD1), and lowers liver triglyceride accumulation by approximately 50%, indicating that DDB1 is necessary for fructose-induced de novo lipogenesis and steatosis in this model.
When mice eat a lot of fructose, a protein called DDB1 breaks down another protein called CRY1. Without CRY1, ChREBPα doesn't get destroyed and builds up in liver cells. This stable ChREBPα turns on genes that make fat, causing fat to accumulate in the liver.
What the research says
1 studyStudy: DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1
When mice eat a lot of sugar (fructose), a protein called DDB1 helps another protein (ChREBPα) stay active and make fat in the liver. When scientists removed DDB1, the fat-making stopped and liver fat dropped by half—proving DDB1 is needed for this process.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.